We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Banco Santander Chile
BSAC
$16.6B
| $3K | ﹤0.01% |
159
| – | – |
|
2002
TriMas Corp
TRS
$1.44B
| $3K | ﹤0.01% |
109
+24
| +28% | +$634 |
|
|
TPC
2003
Tutor Perini Cor
TPC
$5.21B
| $3K | ﹤0.01% |
419
-768
| -65% | -$4.58K |
|
2004
Essential Utilities
WTRG
$11.4B
| $2.99K | ﹤0.01% |
75
-165
| -69% | -$6.92K |
|
2005
IAMGOLD
IAG
$10.5B
| $2.99K | ﹤0.01% |
1,137
| – | – |
|
2006
Ormat Technologies
ORA
$6.65B
| $2.98K | ﹤0.01% |
37
-10
| -21% | -$847 |
|
2007
Autoliv
ALV
$9B
| $2.98K | ﹤0.01% |
35
+5
| +17% | +$433 |
|
2008
Selective Insurance
SIGI
$5.73B
| $2.97K | ﹤0.01% |
31
| – | – |
|
2009
Sinclair Inc
SBGI
$1.03B
| $2.96K | ﹤0.01% |
214
-18
| -8% | -$297 |
|
2010
Calix
CALX
$2.39B
| $2.94K | ﹤0.01% |
59
+3
| +5% | +$145 |
|
2011
WSFS Financial
WSFS
$4.15B
| $2.94K | ﹤0.01% |
78
| – | – |
|
2012
Danaos Corp
DAC
$2.56B
| $2.94K | ﹤0.01% |
44
+18
| +69% | +$1.09K |
|
2013
Lennox International
LII
$15.2B
| $2.94K | ﹤0.01% |
9
| – | – |
|
|
ALLK
2014
DELISTED
Allakos
ALLK
| $2.93K | ﹤0.01% |
673
-999
| -60% | -$4.5K |
|
2015
Rocket Companies
RKT
$38.9B
| $2.93K | ﹤0.01% |
327
-610
| -65% | -$5.31K |
|
2016
Synaptics
SYNA
$4.15B
| $2.9K | ﹤0.01% |
34
-19
| -36% | -$1.65K |
|
2017
Intapp
INTA
$2.91B
| $2.89K | ﹤0.01% |
69
| – | – |
|
2018
Grand Canyon Education
LOPE
$3.98B
| $2.89K | ﹤0.01% |
28
-11
| -28% | -$1.21K |
|
|
CVSA
2019
Covista Inc
CVSA
$4.8B
| $2.88K | ﹤0.01% |
84
| – | – |
|
2020
Quanex
NX
$1.01B
| $2.87K | ﹤0.01% |
107
| – | – |
|
|
NATI
2021
DELISTED
National Instruments Corp
NATI
| $2.87K | ﹤0.01% |
50
+5
| +11% | +$287 |
|
2022
PureCycle Technologies
PCT
$1.45B
| $2.82K | ﹤0.01% |
+264
| New | +$1.91K |
|
2023
Community Health Systems
CYH
$423M
| $2.82K | ﹤0.01% |
640
| – | – |
|
2024
Viking Therapeutics
VKTX
$4B
| $2.8K | ﹤0.01% |
173
| – | – |
|
2025
Outset Medical
OM
$90.8M
| $2.8K | ﹤0.01% |
9
-4
| -31% | -$1.22K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.